⌘K

Login Start Free

Home/Filings/4/0001209191-21-026419

4//SEC Filing

Civik Thomas 4

Accession 0001209191-21-026419

CIK 0001175505other

View on SEC.gov Company Profile

Filed

Apr 12, 8:00 PM ET

Accepted

Apr 13, 1:05 PM ET

Size

4.9 KB

Accession

0001209191-21-026419

Insider Transaction Report

Form 4

Period: 2021-04-09

FIVE PRIME THERAPEUTICS, INC.FPRX

DirectorPresident and CEO

Transactions

Tax Payment
Common Stock
2021-04-09$37.94/sh−11,088$420,679→ 68,971 total

Footnotes (1)

[F1]Includes 3,859 shares acquired on November 15, 2020 and 1,200 shares acquired on April 1, 2021, in each case, pursuant to Five Prime Therapeutics, Inc.'s 2013 Employee Stock Purchase Plan.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

FIVE PRIME THERAPEUTICS, INC.

CIK 0001175505

Entity typeother

Related Parties

1

filerCIK 0001723092

Filing Metadata

Form type: 4
Filed: Apr 12, 8:00 PM ET
Accepted: Apr 13, 1:05 PM ET
Size: 4.9 KB

View on SEC.gov